(Q48027581)

7 February 2018

title

Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming. (English)

1 reference

7 February 2018

main subject

Plasmodium falciparum

0 references

7

Adrian V S Hill

1 reference

7 February 2018

6

Margaret Pinder

1 reference

7 February 2018

5

Robin Bailey

1 reference

7 February 2018

Magdalena Plebanski

8

object named as

Magdalena Plebanski

1 reference

7 February 2018

author name string

Edwin A M Lee

1

1 reference

7 February 2018

Katie L Flanagan

2

1 reference

7 February 2018

Gabriela Minigo

3

1 reference

7 February 2018

William H H Reece

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

36

1 reference

7 February 2018

page(s)

1168-1178

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Transient cross-reactive immune responses can orchestrate antigenic variation in malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Association of malaria parasite population structure, HLA, and immunological antagonism.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 1. Diversity of enzymes, 2D-PAGE proteins and antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Dependency on interleukin-1 of primary human in vitro T cell responses to soluble antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

In vitro primary responses of human T cells to soluble protein antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Molecular mechanisms underlying functional T-cell unresponsiveness.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Role of mononuclear phagocytes in elimination of Plasmodium chabaudi AS infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Common west African HLA antigens are associated with protection from severe malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

High recombination rate in natural populations of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526010

7 January 2021

Identifiers

DOI

10.1002/EJI.200526010

1 reference

7 February 2018

PubMed ID

16619284

1 reference

7 February 2018